Reasonable Growth, Debt Levels, and a High ROIC Make NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Appealing to Quality Investors.

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is suited for quality investing. Investors should of course do their own research, but we spotted NEUROCRINE BIOSCIENCES INC showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

A Deep Dive into NEUROCRINE BIOSCIENCES INC's Quality Metrics.

• The 5-year revenue growth of NEUROCRINE BIOSCIENCES INC has been remarkable, with 33.13% increase. This showcases the company's strong performance in driving revenue growth and indicates its competitiveness within the market.
• NEUROCRINE BIOSCIENCES INC demonstrates impressive performance in terms of ROIC excluding cash and goodwill, with a 22.89% ratio. This highlights the company's efficient utilization of capital and its focus on maximizing returns for investors.
• With a Debt/Free Cash Flow Ratio of 0.2, NEUROCRINE BIOSCIENCES INC exhibits solid financial health and responsible debt management practices. This ratio indicates the company's ability to generate ample free cash flow to meet its debt obligations and pursue growth opportunities.
• NEUROCRINE BIOSCIENCES INC exhibits impressive Profit Quality (5-year) with a 208.0% ratio, reflecting its consistent ability to generate high-quality profits. This metric underscores the company's strong financial performance and commitment to delivering sustainable earnings.
• NEUROCRINE BIOSCIENCES INC has consistently achieved strong EBIT growth over the past 5 years, with a 60.65% increase. This underscores the company's effective management of its operating income and suggests a positive outlook for future profitability.
• The EBIT 5-year growth of NEUROCRINE BIOSCIENCES INC has outpaced its Revenue 5-year growth, reflecting the company's focus on optimizing its profitability and generating sustainable earnings. This trend underscores its strong financial management.

What is the full fundamental picture of NASDAQ:NBIX telling us.

Every day, ChartMill assigns a Fundamental Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various fundamental indicators and properties.

Overall NBIX gets a fundamental rating of 8 out of 10. We evaluated NBIX against 576 industry peers in the Biotechnology industry. NBIX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NBIX is growing strongly while it also seems undervalued. This is an interesting combination This makes NBIX very considerable for value and growth and quality investing!

Check the latest full fundamental report of NBIX for a complete fundamental analysis.

More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.